Invention Grant
- Patent Title: Compounds and compositions for targeting cancer stem cells
-
Application No.: US14642931Application Date: 2015-03-10
-
Publication No.: US09381184B2Publication Date: 2016-07-05
- Inventor: Chiang Jia Li , David Leggett , Youzhi Li , Wei Li
- Applicant: BOSTON BIOMEDICAL, INC.
- Applicant Address: US MA Norwood
- Assignee: Boston Biomedical, Inc.
- Current Assignee: Boston Biomedical, Inc.
- Current Assignee Address: US MA Norwood
- Agency: Arent Fox LLP
- Main IPC: C07D307/92
- IPC: C07D307/92 ; A61K31/27

Abstract:
The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, methods of producing these naphthofuran compounds, polymorphs, purified compositions and/or particle forms, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
Public/Granted literature
- US20150183756A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS Public/Granted day:2015-07-02
Information query